Company Intelligence
OncoRevive
OncoRevive provides enterprise-grade artificial intelligence solutions, delivering specialized Developing a nanotechnology-based AI-powered blood test for cancer monitoring technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Melbourne, Australia
- Website
- oncorevive.com
- Founded
- 2025
- Stage
- Techstars Tech Central Sydney powered by NSW Government
- Status
- Active
- Products
- 1
- Reports
- 4
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
OncoRevive is an Enterprise Software AI company based in Melbourne, Australia, founded in 2025.
OncoRevive develops developing a nanotechnology-based AI-powered blood test for cancer monitoring.
What it builds
Developing a nanotechnology-based AI-powered blood test for cancer monitoring
Why It Matters
OncoRevive provides enterprise-grade artificial intelligence solutions, delivering specialized Developing a nanotechnology-based AI-powered blood test for cancer monitoring technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
OncoRevive
Explore OncoRevive by OncoRevive. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical architecture, and…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
OncoRevive
Industry
Products
Capabilities
- Developing a nanotechnology-based AI-powered blood test for cancer monitoring
Features
- Developing a nanotechnology-based AI-powered blood test for cancer monitoring
Country
Related companies
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does OncoRevive do?
OncoRevive specializes in artificial intelligence, developing Developing a nanotechnology-based AI-powered blood test for cancer monitoring to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is OncoRevive based and when was it founded?
OncoRevive is based in Australia and was founded in 2025.
What are the main products offered by OncoRevive?
The flagship platform from OncoRevive is Developing a nanotechnology-based AI-powered blood test for cancer monitoring, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of OncoRevive?
OncoRevive primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Request a correction if you represent this company or believe information is inaccurate.